Cargando…

Relationship of Tubule Formation, Indian File Pattern and Apocrine Change With Estrogen and Progesterone Receptors and HER2 Immunostaining

Objectives: In breast carcinomas, histomorphological features like low-grade and lobular differentiation are associated with estrogen receptor (ER) and progesterone receptor (PR) expression. Apocrine carcinoma is associated with human epidermal growth factor receptor 2 (HER2) positivity. Studies hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Divya, Agarwal, Akansha, Anthony, Michael L, Paul, Pranoy, Singh, Monika, Rao, Shalinee, Ravi, Bina, Chowdhury, Nilotpal
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Pathology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650915/ https://www.ncbi.nlm.nih.gov/pubmed/36381921 http://dx.doi.org/10.7759/cureus.30204

Ejemplares similares

Detecting Human Epidermal Growth Factor Receptor 2 (HER2) Amplification: Proof of Concept of an Alternative Approach
por: Mudgal, Shikha, et al.
Publicado: (2023)

Comparison of Fluorometric and UV Spectrophotometric Findings for DNA Isolated From Formalin-Fixed Paraffin-Embedded Blocks, Fine Needle Aspiration Cytology Smears, and Blood
por: Paul, Pranoy, et al.
Publicado: (2021)

Hyaline Vascular Type of Castleman Disease: Diagnostic Pitfalls on Cytology and Its Clinical Relevance
por: Singh, Neha, et al.
Publicado: (2021)

Clinical and Biochemical Correlation With Cytomorphological Findings of Lymphocytic Thyroiditis: An Experience at a Tertiary Centre in the Himalayan Foothills
por: Singh, Monika, et al.
Publicado: (2022)

Immunoexpression of Programmed Death-1 Receptor (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Non-Small-Cell Lung Carcinoma and Its Correlation With Other Clinicopathological Parameters: A Cross-Sectional Study From North India
por: Anthony, Michael L, et al.
Publicado: (2022)

Expression of Programmed Cell Death-1 (PD-1) and Its Ligand (PD-L1) in Breast Cancers and Its Association with Clinicopathological Parameters
por: Mehan, Anoushika, et al.
Publicado: (2021)

Thalassemia and Hemoglobinopathy Screening in Women Attending Antenatal Clinic at a Tertiary Care Center in Uttarakhand, India: A Re-look at the Laboratory Parameters Mandating High-Performance Liquid Chromatography Workup
por: Singh, Neha, et al.
Publicado: (2023)

Breast Atypical Apocrine Adenosis: A Case Report and Literature Review
por: Khan, Kashuf A, et al.
Publicado: (2020)

Estrogen and Progesterone Receptor Expression in Breast Carcinoma and Its Association With Clinicopathological Variables Among the Pakistani Population
por: Sohail, Shahzada K, et al.
Publicado: (2020)

Evaluation of HER2Neu Status in Periampullary Cancers in Tertiary Care Centre in Northern India: A Three-Year Retrospective Study
por: Qayoom, Sumaira, et al.
Publicado: (2023)

Pathologic Remodeling of Endoneurial Tubules in Human Neuromas
por: Karsy, Michael, et al.
Publicado: (2018)

Utility of Ethylene-Diamine-Tetraacetic Acid Buffer Solution With Boric Acid for Immunostaining of Specimens Stored for an Extended Period
por: Hatta, Hideki, et al.
Publicado: (2021)

Correlation of HER2 With p53 and p63 in Urothelial Bladder Carcinoma
por: Ponnaboina, Divya Madhuri, et al.
Publicado: (2023)

Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2013)

Membranous location of EGFR immunostaining is associated with good prognosis in renal cell carcinoma
por: Kallio, J P, et al.
Publicado: (2003)

Characterization of Progesterone Receptor Expression in Intracranial Meningiomas of Patients Treated in a High-Complexity Hospital in Bogota, Colombia
por: Ramirez Grueso, Raul, et al.
Publicado: (2020)

Review of the Role of HER2/neu in Colorectal Carcinomas
por: Achalla, Lakshmi Sai Vijay, et al.
Publicado: (2022)

Estrogen Receptor, Progesterone Receptor, and HER-2 Expression in Recurrent Pleomorphic Adenoma
por: de Souza, Ana Amélia, et al.
Publicado: (2019)

Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
por: Wang, Caifeng, et al.
Publicado: (2020)

A Rare Case of Gastrointestinal Mucormycosis
por: Kaur, Jasneet, et al.
Publicado: (2021)

Early versus late distant metastasis and adjuvant chemotherapy alone versus both radiotherapy and chemotherapy in molecular apocrine breast cancer
por: Liu, Xiaozhen, et al.
Publicado: (2016)

Overexpression of Her-2 in Biopsy-Proven Urothelial Carcinoma Patients From Pakistan
por: Chughtai, Anila, et al.
Publicado: (2022)

Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization
por: Annaratone, Laura, et al.
Publicado: (2017)

Stromal Clues in Endometrial Carcinoma: Loss of Expression of β-Catenin, Epithelial-Mesenchymal Transition Regulators, and Estrogen-Progesterone Receptor
por: Senol, Serkan, et al.
Publicado: (2016)

Clinicopathologic Features of Metaplastic Breast Carcinoma: Experience From a Tertiary Cancer Center of North India
por: Damera, Vineeth V, et al.
Publicado: (2022)

Her2 Status Discrepancy Between Core Needle Biopsy and Surgically Resected Mastectomy Specimen: A Clinical Case
por: Vasques, Ana Carolina, et al.
Publicado: (2023)

Detection of Proximal Tubule Involvement by BK Polyomavirus in Kidney Transplant Recipients With Urinary Sediment Double-Immunostaining
por: Huang, Yang, et al.
Publicado: (2020)

Study of Programmed Death Ligand 1 and EGFR/HER2 Expression in Non-Small-Cell Lung Carcinoma With a Clinicopathological Spectrum
por: Laishram, Devina, et al.
Publicado: (2021)

Human Epidermal Growth Factor Receptor 2 (HER2) Expression in Colorectal Carcinoma: A Potential Area of Focus for Future Diagnostics
por: Kaur, Simrandeep, et al.
Publicado: (2022)

Impact of Human Epidermal Growth Factor Receptor 2 (HER2) Low Status in Response to Neoadjuvant Chemotherapy in Early Breast Cancer
por: Alves, Fátima R, et al.
Publicado: (2022)

Human Epidermal Growth Factor Receptor 2 (HER2) Expression by Immunohistochemistry and Its Clinical Significance in Hepatocellular Carcinoma: A Single-Center Analysis
por: Magalhães, Denise, et al.
Publicado: (2023)

Alternative Strategy Adopted in Practical Assessment for Pathology Postgraduate Certification Examination Amidst COVID-19 Nationwide Lockdown: An Indian Experience with a Novel Hybrid Method of Assessment
por: Rao, Shalinee, et al.
Publicado: (2021)

Apocrine Hidrocystoma of the Cheek
por: Lee, Myung Jun, et al.
Publicado: (2012)

Apocrine Adenocarcinoma of the Vulva
por: Kajal, Babita, et al.
Publicado: (2013)

Apocrine lesions of the breast
por: Quinn, Cecily M., et al.
Publicado: (2021)

PROGNOSTIC IMPACT OF LOW ESTROGEN AND PROGESTERONE POSITIVITY IN LUMINAL B (HER2 NEGATIVE) BREAST CANCER
por: Rajc, Jasmina, et al.
Publicado: (2018)

The Utility of Oncotype DX for Adjuvant Chemotherapy Treatment Decisions in Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, Node-negative Breast Cancer
por: Rizki, Hirah, et al.
Publicado: (2020)

HER2-positive apocrine carcinoma of the breast: a population-based analysis of treatment and outcome
por: Skenderi, Faruk, et al.
Publicado: (2022)

A Comprehensive Review of Pathological Examination in Forensic Medicine: Past, Present, and Future
por: Singh, Dezy, et al.
Publicado: (2022)

The Add-On Effect of Fluorouracil, Epirubicin, and Cyclophosphamide Regimens for Neoadjuvant Chemotherapy in Human Epidermal Receptor 2 (HER2)-Positive Breast Cancer: A Single-Center Retrospective Study
por: Yoshino, Ryusei, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_76u6ioss2gji619b9mba3hvlu0